This web site contains information about the March 19 announcement that the University of Wisconsin Comprehensive Cancer Center has been selected as one of two clinical trials for the cancer drug endostatin. For assistance with any of the materials found on this web site, please contact Lisa Brunette (608-263-5830, labrunet@facstaff.wisc.edu) of the Center for Health Sciences Public Affairs. Patient Information: Prospective patients can click on the link below to get more information or to find out how to contact the appropriate people at the UW-Madison Comprehensive Cancer Center.

• News release
  
• Information for prospective patients
  
• Comprehensive Cancer Center background: Historical timeline
  
• Images/graphics for media use
  
• National Cancer Institute: Cancer Therapy Evaluation Program (CTEP)
  
• National Cancer Institute: Cancer Trials Web Site
  
• UW Comprehensive Cancer Center